Headache News and Research

Latest Headache News and Research

Parts of Lake Tahoe close after chipmunks test positive for plague

Officials are closing some areas on the south shore of Lake Tahoe after some chipmunks tested positive for plague, an infectious disease that affects both humans and other mammals.

4 Aug 2021

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based COVID-19 vaccine mRNA-1273 (Moderna). The trial findings reveal that the fractional dose regimen of the Moderna vaccine is well tolerated and safe and is capable of inducing robust antibody responses in vaccine recipients. The study is currently available on the medRxiv* preprint server.

2 Aug 2021

Study examined 1,497 full-vaccinated healthcare workers for breakthrough infections

A new study published in The New England Journal of Medicine found that in a very small number of cases, people with breakthrough infections might suffer long-lasting COVID-19 symptoms.

2 Aug 2021

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Nanocovax is a protein subunit vaccine that contains the full-length spike stabilized by the addition of two prolines

29 Jul 2021

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

A new study published on the preprint server medRxiv* presents an analysis of the differences between recorded vaccination side effects vs. early COVID-19 symptoms. The researchers focused on four vaccines, namely, Pfizer-BioNTech (PB) mRNA (BNT162b2) vaccine, based on messenger ribonucleic acid encoding the viral spike protein; the Moderna mRNA (mRNA-1273) vaccine; the Oxford-AstraZeneca (O-AZ) adenovirus-vectored vaccine; and the Janssen adenovirus-vectored Ad26.COV2.S).

26 Jul 2021

CDC monitoring over 200 individuals possibly exposed to monkeypox

The United States Centers for Disease Control and Prevention (CDC) is monitoring over 200 people who may have been exposed to the monkeypox virus.

22 Jul 2021

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Evidence of the sustained benefits of an investigational antipsychotic treatment for people with dementia-related psychosis has been published.

22 Jul 2021

Study associates feelings of discrimination and low status with long COVID-19 symptoms

A recent study, released as a preprint on the medRxiv* server, examines the correlation of these symptoms with the patient’s socioeconomic status (SES) and perception of social discrimination, along with other social factors. The researchers found that the first two factors are associated strongly with long-term symptoms of COVID-19.

21 Jul 2021

New study disproves suspicion that dengue raises risk of zika-related microcephaly

A pregnant woman infected by zika virus does not face a greater risk of giving birth to a baby with microcephaly if she has previously been exposed to dengue virus, according to a Brazilian study that compared data for pregnant women in Rio de Janeiro and Manaus.

20 Jul 2021

Study examines asymptomatic, presymptomatic and symptomatic transmission dynamics of SARS-CoV-2

A new preprint, available on the medRxiv* server, describes how researchers found at least a third of infected individuals to be asymptomatic, but that a fifth of them successfully passed on the virus to others. In comparison, about a quarter of symptomatic cases did so, especially when the symptoms included fever, cough and shortness of breath. In these circumstances, up to 30% of them transmitted the virus.

13 Jul 2021

New analysis finds muscle relaxant drugs to be largely ineffective for low back pain

Muscle relaxant drugs are largely ineffective for low back pain, despite being widely prescribed for this condition, suggests an analysis of the latest evidence published by The BMJ today.

8 Jul 2021

Women at higher risk of post-COVID-19 syndrome

To better understand post-COVID sequelae, researchers at the University Hospital Basel and the University Hospital Zurich conducted a multicentre prospective observational cohort study.

8 Jul 2021

Study explores the prevalence of long COVID in England

A review of long COVID studies conducted in March 2021 summarized the available literature on the persistent symptoms after acute COVID-19. The review also reported that most studies included hospitalized patients who had a higher prevalence of persistent symptoms compared to two community-based studies.

7 Jul 2021

Novavax COVID-19 vaccine demonstrates ~90% efficacy against SARS-CoV-2

The findings reveal that the two-dose regimen of the vaccine is almost 90% effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Moreover, the vaccine shows high efficacy against the B.1.1.7 variant (Alpha) of SARS-CoV-2.

5 Jul 2021

Dietary alteration of certain fatty acids can reduce severity of headaches

Migraine is one of the largest causes of disability in the world. Existing treatments are often not enough to offer full relief for patients.

2 Jul 2021

The use of flavonoids as antiviral agents against SARS-CoV-2

Researchers in Iran have undertaken a comprehensive review of flavonoids and their antiviral potential against SARS-CoV-2.

2 Jul 2021

High omega 3 diet associated with reduction of headaches

Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today.

2 Jul 2021

Expanding covid-19 symptom list could help improve the UK’s pandemic response

The UK should expand its official list of symptoms for defining covid-19 to prevent cases being missed and help improve the UK’s pandemic response, say experts in The BMJ today.

2 Jul 2021

What's behind COVID-19 vaccine side effects?

A growing concern among coronavirus vaccines is the vaccine side effects. Fear or misinformation about side effects may fuel vaccine hesitancy, contributing to low vaccination rates. Australian researchers recently published an article in Science Immunology to discuss why people develop side effects and their benefits.

28 Jun 2021

An oral pill for COVID-19? Molnupiravir shows promise

Recently, researchers reported molnupiravir as the first oral and direct-acting antiviral that is highly effective at reducing SARS-CoV-2 levels.

27 Jun 2021

Headache News and Research

Latest Headache News and Research

Parts of Lake Tahoe close after chipmunks test positive for plague

Intradermal administration of low-dose mRNA COVID-19 vaccine induces strong immune response, study finds

Study examined 1,497 full-vaccinated healthcare workers for breakthrough infections

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

CDC monitoring over 200 individuals possibly exposed to monkeypox

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Study associates feelings of discrimination and low status with long COVID-19 symptoms

New study disproves suspicion that dengue raises risk of zika-related microcephaly

Study examines asymptomatic, presymptomatic and symptomatic transmission dynamics of SARS-CoV-2

New analysis finds muscle relaxant drugs to be largely ineffective for low back pain

Women at higher risk of post-COVID-19 syndrome

Study explores the prevalence of long COVID in England

Novavax COVID-19 vaccine demonstrates ~90% efficacy against SARS-CoV-2

Dietary alteration of certain fatty acids can reduce severity of headaches

The use of flavonoids as antiviral agents against SARS-CoV-2

High omega 3 diet associated with reduction of headaches

Expanding covid-19 symptom list could help improve the UK’s pandemic response

What's behind COVID-19 vaccine side effects?

An oral pill for COVID-19? Molnupiravir shows promise

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Headache News and Research

Latest Headache News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in